why choose us

First received: October 01, 2024

Clinical Trial: Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Ovarian Cancer

Study Type: INTERVENTIONAL


Official Title: Intraoperative Esketamine for Prevention of Depressive Symptoms After Cytoreductive Surgery in Ovarian Cancer: a Controlled, Randomized Clinical Trial

Brief Summary: The goal of this clinical trial is to learn if intraoperative administration of esketamine would prevent or mitigate postoperative depressive symptoms after cytoreductive surgery in ovarian cancer.The main questions it aims to answer are:Whether a single low dose of esketamine administered would reduce the postoperative depressive symptoms three days after cytoreductive surgery in ovarian cancer?Whether a single low dose of esketamine administered would relief the postoperative sleep disturbance, postoperative…

Read more